Journal article
The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
Abstract
BackgroundThe Global Initiative for Asthma recommends the use of as-needed low-dose inhaled corticosteroid (ICS)-formoterol as a preferred controller therapy for patients with mild asthma. These recommendations were based, in part, on evidence from the SYGMA 1 and 2 studies of as-needed budesonide-formoterol. This analysis aimed to compare the cost-effectiveness of as-needed budesonide-formoterol to low-dose maintenance ICS plus as-needed …
Authors
Sadatsafavi M; FitzGerald JM; O’Byrne PM; Soliman M; Sriskandarajah N; Vicente C; Golam SM
Journal
Allergy, Asthma & Clinical Immunology, Vol. 17, No. 1,
Publisher
Springer Nature
Publication Date
December 2021
DOI
10.1186/s13223-021-00610-w
ISSN
1710-1484